Canada: Food and Drugs Law

In Nguyen, three respondents and several others were accused of various offences relating to an alleged conspiracy to produce cannabis. While the Respondents obtained a stay of proceedings...

Le Canada a ratifié l'Accord Canada–États-Unis–Mexique avec un engagement envers un cadre de propriété intellectuelle stable pour l'innovation pharmaceutique. Cependant, le traitement des numéros d'identification de médicament (DIN) « dormants » crée une incertitude réglementaire qui lie les protections de PI au statut de commercialisation plutôt qu'à l'approbation réglementaire. Cette approche soulève des questions sur la con

This article provides an overview of the regulatory regime and associated intellectual property rights for veterinary drug products and provides an update on recent issues, focusing on features that differ from drugs for human use.

When Canada ratified the Canada–United States–Mexico Agreement (CUSMA), it signalled a policy commitment to a stable and predictable intellectual property (IP) framework that supports pharmaceutical innovation...

The Federal Court of Canada has found that a C$5 billion class action alleging an industry-wide conspiracy to fix generic drug prices in Canada has no basis in fact.

Canada is widely recognized as one of the world's leading agricultural powerhouses. We're home to highly productive farms, strong export markets and a growing ecosystem of agri-food innovators.

In December 2025, Health Canada released proposed Clinical Trials Regulations (the proposed regulations), which would establish a new regulatory framework for clinical trials involving drugs for human use.

On January 29, 2026, Canada's Drug Agency (CDA) published Improvements to the Drug Reimbursement Review Process, which includes a section for consultation on proposed changes to the reimbursement review process.

In 2025, Canadian governments and producer‑responsibility organizations ("PROs") continued advancing innovative product stewardship and extended producer responsibility...